Arbutus Biopharma Corporation
ABUS
$3.59
$0.010.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -30.92% | -12.79% | -2.68% | -4.76% | -6.88% |
| Total Receivables | -45.57% | -49.54% | 14.02% | -12.11% | -20.93% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -6.26% | -30.16% | -45.61% | -41.50% | 12.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -30.43% | -14.03% | -3.57% | -6.24% | -6.66% |
|
|
|||||
| Total Current Assets | -30.43% | -14.03% | -3.57% | -6.24% | -6.66% |
| Net Property, Plant & Equipment | -97.21% | -97.07% | -28.46% | -28.08% | -23.85% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -35.48% | -22.14% | -8.79% | -11.47% | -9.49% |
|
|
|||||
| Total Accounts Payable | -50.19% | -40.15% | -28.14% | 2.43% | 154.02% |
| Total Accrued Expenses | -71.39% | -13.32% | -25.54% | -38.19% | 8.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.47% | 12.15% | 13.65% | 13.59% | 14.11% |
| Total Finance Division Other Current Liabilities | -93.04% | 10.19% | -35.79% | -5.20% | -28.01% |
| Total Other Current Liabilities | -93.04% | 10.19% | -35.79% | -5.20% | -28.01% |
| Total Current Liabilities | -77.77% | -4.26% | -30.55% | -15.23% | -7.88% |
|
|
|||||
| Total Current Liabilities | -77.77% | -4.26% | -30.55% | -15.23% | -7.88% |
| Long-Term Debt | -33.27% | -31.07% | -30.55% | -34.46% | -33.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -49.74% | -46.99% | -39.99% | -34.67% | -30.50% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 34.95% | 72.07% | 72.21% | 13.05% | 11.48% |
| Total Liabilities | -46.02% | 6.17% | -10.53% | -14.64% | -10.78% |
|
|
|||||
| Common Stock & APIC | 0.99% | 2.81% | 4.26% | 4.45% | 4.48% |
| Retained Earnings | -4.13% | -5.91% | -5.48% | -6.10% | -6.23% |
| Treasury Stock & Other | 0.25% | 0.42% | 0.59% | 1.62% | 2.34% |
| Total Common Equity | -32.24% | -30.95% | -8.16% | -10.43% | -9.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -32.24% | -30.95% | -8.16% | -10.43% | -9.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -32.24% | -30.95% | -8.16% | -10.43% | -9.09% |
|
|
|||||